Chuangmei Pharmaceutical

I: Investor Relations

Announcements and Circulars

The current position: Home>Investor Relations>Announcements and Circulars

Year

2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014

012025-04

Monthly Returns - Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2025
282025-03

(1)PROPOSED AMENDMENTS TO THE ARTICLES OF ASSOCIATION；(2)PROPOSED AMENDMENTS TO THE RULES OF PROCEDURES FOR SHAREHOLDERS' MEETINGS; (3) PROPOSED AMENDMENTS TO THE RULES OF PROCEDURES FOR BOARD MEETINGS; AND (4)PROPOSED AMENDMENTS TO THE RULES OF PROCEDURES FOR BOARD OF SUPERVISORS' MEETINGS
282025-03

FINAL DIMDEND FOR THE YEAR ENDED 31 DECEMBER 2024
282025-03

ANNOUNCEMENT OF ANNUAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2024
172025-03

NOTICE OF BOARD MEETING
032025-03

Monthly Returns - Monthly Return of Equity Issuer on Movements in Securities for the month ended 28 February 2025
032025-02

Monthly Returns - Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2025
022025-01

Monthly Returns - Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2024
272024-12

POLL RESULTS OF THE 2024 SECOND EXTRAORDINARY GENERAL MEETING HELD ON 27 DECEMBER 2024
092024-12

FORM OF PROXY FOR USE AT THE 2024 SECOND EXTRAORDINARY GENERAL MEETING TO BE HELD ON 27 DECEMBER 2024 OR AT ANY ADJOURNMENT THEREOF
092024-12

NOTICE OF EXTRAORDINARY GENERAL MEETING
092024-12

RENEWAL OF CONTINUING CONNECTED TRANSACTIONS IN RELATION TO FRAMEWORK SALES AGREEMENT AND FRAMEWORK PURCHASE AGREEMENT AND NOTICE OF EXTRAORDINARY GENERAL MEETING

1 2 3 4 5

The Enterprise OA